Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
adrenergic blocker
adverse drug reaction
alcohol block, subarachnoid
alpha adrenergic blocker
amenorrhea
autonomic dysfunction
benign essential tremor
beta adrenergic blocker
cauda equina
cauda equina, lesion of
cerebral ischemia
dibenzyline
diplopia, monocular
drug induced neurologic disorders
ejaculation
ejaculation, retrograde
erection
fertility
guanethidine
headache
headache, post traumatic
headache, vascular
Horner's syndrome
hyperhidrosis
impotence
labetalol
midodrine
muscle pain
myopathy
myopathy, toxic
myositis
neuropathy, peripheral
orgasm
orthostatic hypotension
orthostatic hypotension, idiopathic
orthostatic hypotension, treatment of
pregnancy, neurologic complications in
priapism
propranolol
ptosis
pupil, abnormality in neurologic disorders
pupil, dilated, unilateral
review article
rhizotomy
rhizotomy, phenol
risk factors
sexual dysfunction in neurologic disease
sexual intercourse
Shy-Drager syndrome
spinal cord, injury of
spinal cord, injury, functional capacity of patient with
spinal cord, injury, sexual dysfunction in
steroid
subarachnoid hemorrhage
subarachnoid hemorrhage, treatment of
sympathectomy
sympatholytic agent
syncope
trauma
treatment of neurologic disorder
tremor
vasopressin
Showing articles 400 to 450 of 3492 << Previous Next >>

Mechanisms, Causes, and Effects of Hypercapnia
UptoDate Dec, Feller-Kopman, D.J. & Schwartzstein, R.M., 2016

Carotid Near-Occlusion: A Comprehensive Review, Part 2- Prognosis and Treatment, Pathophysiology, Confusions, and Areas for Improvement
AJNR 37:200-204, Johansson, E. & Fox, A.J., 2016

Statin-Associated Autoimmune Myopathy
NEJM 374:664-669, Mammen, A.L., 2016

Clinicopathologic Conference, Cerebral Mucormycosis
NEJM 374:671-680, Case 5-2016, 2016

Acute Cholecystitis During Treatment with Alemtuzumab in 3 Patients with RRMS
Neurol 87:2380-2381, Pfeuffer, S.,et al, 2016

Acute Hippocampal and Chronic Diffuse White Matter Involvement in Severe Methanol Intoxication
Neurol 87:2382-2383, Takeshige, H.,et al, 2016

Myasthenia Gravis
NEJM 375:2570-2581, Gilhus, N.E.,et al, 2016

Drip and Ship Versus Direct to Comprehensive Stroke Center
Stroke 48:233-238, Holodinsky, J.K.,et al, 2016

Clinicopathologic Conference, Oligdendroglioma II/IV with IDH1 R132H mutation and codelation of 1p and 19q
NEJM 375:2381-2389, Case 38-206, 2016

Treatment of Carotid Intramural Thrombus with TPA
JAMA Neurol 73:1496, Bennett, A.,et al, 2016

Treatment of Neurosarcoidosis
Neurol 87:2517-2521, Bitoun, S.,et al, 2016

Tongue Fasciculations in Organophosphate Poisoning
NEJM 375:e47, Bande, L.R., 2016

Trial of Decompressive Craniectomy for Traumatic Intracranial Hypertension
NEJM 375:1119-1130,1183, Hutchinson, P.J.,et al, 2016

Stroke Outcomes with use of Antithrombotics within 24 hours after Recanalization Treatment
Neurol 87:996-1002, Jeong, H.G.,et al, 2016

Herpes Simplex Encephalitis in an Immunocompromised Adult with Novel MRI and Pathology Findings
Clin Neuroradiol DOI: 10.1007/s00062-016-0536-x, Modak, J.,et al, 2016

Global and Regional Effects of Potentially Modifiable Risk Factors Associated with Acute Stroke in 32 Countries (INTERSTROKE): A Case-Control Study
Lancet 388:761-775,733, ODonnell M.J.,et al, 2016

A 57-year-old Woman with Ataxia and Oscillopsia
Neurol 87:e61-e64, Bradshaw, M.J.,et al, 2016

A Case of Subacute Cognitive Decline in a 76-year-old Man
Neurol 87:e124-e128, MacLellan, A.,et al, 2016

A 73-year-old Man with Sarcoidosis and Multifocal Ischemic Strokes
Neurol 87:e119-e123, Pichler, M.,et al, 2016

Superior MRI Outcomes with Alemtuzumab Compared with Subcutaneous Interferon �-1a in MS
Neurol 87:1464-1472, Arnold, D.L.,et al, 2016

Safety and Outcome of Intra-Arterial Treatment for Basilar Artery Occlusion
JAMA Neurol 73:1225-1230, Van Houwelingen, R.C.,et al, 2016

Clinical Relevance of Microbleeds in Acute Stroke Thrombolysis
Neurol 87:1534-1541, Charidimou, A.,et al, 2016

A Young Man with Recurrent Coma and Refractory Status Epilepticus
JAMA Neurol 73:1243-1244, Sheikh, Z.,et al, 2016

Metronidazole-Associated Encephalopathy
NEJM 374:1465, Baden, L.R., 2016

A 76-Year-Old Man with Acute-Onset Left-Sided Weakness and Numbness
Neurol 86:e156-e160, Renthal, W.,et al, 2016

One-Year Risk of Stroke after Transient Ischemic Attack or Minor Stroke
NEJM 374:1533-1542,1577, Amarenco, P.,et al, 2016

Rituximab Treatment for Autoimmune Limbic Encephalitis in an Institutional Cohort
Neurol 86:1683-1691,1655, Lee, W.J.,et al, 2016

Tocilizumab for Induction and Maintenance of Remission in Giant Cell Arteritis: A Phase 2, Randomised, Double-Blind, Placebo-Controlled Trial
Lancet 387:1921-1927,1882, Villiger, P.M.,et al, 2016

Clinicopathologic Conference, Neurosarcoidosis
NEJM 374:1966-1975, Case 15-2016, 2016

Fulminant Central Nervous System Nocardiosis in a Patient Treated with Alemtuzumab for Relapsing-Remitting Multiple Sclerosis
JAMA Neurol 73:757-759, Penkert, H.,et al, 2016

Risk of Symptomatic Intracerebral Hemorrhage after Intravenous Thrombolysis in Patients with Acute Ischemic Stroke and High Cerebral Microbleed Burden
JAMA Neurol 73:675-683,632, Tsivgoulis, G.,et al, 2016

Imaging, Intervention, and Workflow in Acute Ischemic Stroke: The Calgary Approach
AJNR 37:978-984, Zerna, C.,et al, 2016

Orolingual Angioedema During or After Thrombolysis for Cerebral Ischemia
Stroke 47:1825-1830, Myslimi, F.,et al, 2016

Safety and Diagnostic Value of Brain Biopsy in HIV patients: a Case Series and Meta-Analysis of 1209 Patients
JNNP 87:722-733, Lee, A.M.,et al, 2016

And Why Not Thrombolysis in the Ambulance (At Least for Some)?
Neurol 87:214-219, Rosenberg, G. & Steiner, I., 2016

Rebound Syndrome in Patients with Multiple Sclerosis after Cessation of Fingolimod Treatment
JAMA Neurol 73:790-794, Hatcher, S.E.,et al, 2016

International Consensus Guidance for Management of Myasthenia Gravis
Neurol 87:419-425, Sanders, D.B.,et al, 2016

Repeated Intravenous Thrombolysis for Early Recurrent Stroke
Stroke 47:2133-2135, Kahles, T.,et al, 2016

Primary Prevention of Stroke
JAMA 316:658-659, Steiger, N. & Cifu, A.S., 2016

Effect of a Cerebral Protection Device on Brain Lesions Following Transcatheter Aortic Valve Implantation in Patients with Severe Aortic Stenosis
JAMA 316:592-601,587, Haussig, S.,et al, 2016

Favorable Bridging Therapy Based on DWI-FLAIR Mismatch in Patients with Unclear-Onset Stroke
AJNR 37:88-93, Mourand, I.,et al, 2016

Scientific Rationale for the Inclusion and Exclusion Criteria for Intravenous Alteplase in Acute Ischemic STroke
Stroke 47:581-641, Demaerschalk, B.M.,et al, 2016

Intravenous Thrombolysis in Patients Dependent on the Daily Help of Others Before Stroke
Stroke 47:450-456, Gensicke, H.,et al, 2016

Natalizumab-Related PML 2 Weeks after Negative Anti-JCV Antibody Assay
Neurol 86:484-486, Gagne, M.S.,et al, 2016

Telemedicine in Prehospital Stroke Evaluation and Thrombolysis
JAMA Neurol 73:162-168, Itrat, A.,et al, 2016

Validation of Clinicoradiological Criteria for the Diagnosis of Cerebral Amyloid Angiopathy-Related Inflammation
JAMA Neurol 73:197-202, Auriel, E.,et al, 2016

Rapid Multifocal Neurologic Decline in an Immunocompromised Patient
JAMA Neurol 73:226-231, Kromm, J.A.,et al, 2016

Infective Endocarditis
Lancet 387:882-893, Cahill, T.J. & Prendergast, B.D., 2016

Community-Acquired Bacterial Meningitis in Adults with Cancer or a History of Cancer
Neurol 86:860-866, Costerus, J.M.,et al, 2016

Antibiotic-Associated Encephalopathy
Neurol 86:963-971, Bhattacharyya, S.,et al, 2016



Showing articles 400 to 450 of 3492 << Previous Next >>